BGI NOVA™ Metabolic Disease Screening.

	BGI NOVA™ Metabolic Disease Screening.
Purpose	BGI NOVA™ Metabolic Disease Screening: Test determines a baby’s risk for 51 different metabolic disorders including metabolic disorders of amino acids, organic acidemias and fatty acid oxidation deficiencies. Many metabolic disorders are amenable to effective treatment upon timely diagnosis. Early detection and intervention can lead to favorable clinical outcomes.
Test Code	DX0689
Turnaround Time (TAT)	10 Days
Sample Tested	BGI NOVA™ Metabolic Disease Screening: 1 Dried Blood Spot, should be sampled after 72 hours after birth with fully breeding and within 7 days, no later than 20 days.
Methodology	BGI provides newborn testing for inherited metabolic disorders based on tandem mass spectrometry coupled to liquid chromatography (LC-MS/MS) and fluorescence analysis. Genetic Counseling.
Advantages	BGI NOVA™ Metabolic Disease Screening: Comprehensive - simultaneous detection of 51 different metabolic disorders. Affordable – lower price for the test.